You are here

Home

Clinical Trials: Cord Blood

Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM®
Condition:   Alzheimer's Disease
Intervention:   Biological: human umbilical cord blood derived mesenchymal stem cells
Sponsors:   Samsung Medical Center;   Medipost Co Ltd.
Not yet recruiting
Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD
Condition:   Congenital Heart Disease, SRV Dependent
Intervention:   Biological: Autologous mononuclear cells
Sponsors:   Timothy J Nelson, MD, PhD;   Mayo Clinic;   University of Oklahoma;   Children's Hospital of Philadelphia;   Children's Hospital Los Angeles;   Children's Hospitals and Clinics of Minnesota;   Children's Hospital Colorado;   Ochsner Health System;   Children's of Alabama;   Children's Hospital Medical Center, Cincinnati;   The Hospital for Sick Children
Not yet recruiting
Alveolar Cleft Reconstruction Powered by
Condition:   Alveolar Cleft
Intervention:   Procedure: stem cell transplantation
Sponsor:   Makerere University
Not yet recruiting
Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis
Condition:   Ulcerative Colitis
Interventions:   Drug: Prednisone;   Drug: Azathioprine;   Drug: Adalimumab;   Biological: umbilical cord blood mononuclear cells
Sponsor:   Shandong Qilu Stem Cells Engineering Co., Ltd.
Recruiting
UCB Stem Cells for Autism Spectrum Disorders
Condition:   Autism Spectrum Disorder
Intervention:   Other: umbilical cord blood mononuclear stem cells
Sponsor:   St. Petersburg Bekhterev Research Psychoneurological Institute
Active, not recruiting
Umbilical Cord Blood Transfusion in Consolidation Therapy of Elderly Patients With Acute Myeloid Leukemia
Condition:   Leukemia, Myelomonocytic, Acute
Intervention:   Drug: umbilical cord blood
Sponsor:   First Affiliated Hospital Xi'an Jiaotong University
Not yet recruiting
A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia
Condition:   Acute Myeloid Leukemia
Interventions:   Drug: Cyclophosphamide-Fludarabine (Cy/Flu);   Drug: oNKord®
Sponsor:   Glycostem Therapeutics BV
Not yet recruiting
US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease
Conditions:   Sickle Cell Disease;   Umbilical Cord Blood;   Hematopoietic Cell Proliferation
Intervention:   Biological: ECT-001-CB (UM171-Expanded Cord Blood Transplant)
Sponsors:   ExCellThera inc.;   California Institute for Regenerative Medicine (CIRM)
Not yet recruiting
Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome
Conditions:   COVID-19 Infection;   COVID-19-Associated Acute Respiratory Distress Syndrome
Interventions:   Other: Best Practice;   Biological: Mesenchymal Stem Cell
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
Recruiting
CPX-351 Versus Immediate Donor Stem Cell Transplant for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease
Conditions:   Acute Myeloid Leukemia;   Myelodysplastic Syndrome With Excess Blasts-2;   Myeloid Neoplasm
Interventions:   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Liposome-encapsulated Daunorubicin-Cytarabine
Sponsors:   Fred Hutchinson Cancer Research Center;   Jazz Pharmaceuticals
Not yet recruiting

Pages